What is the BMFDC?

History of the BMFDC

Image: Idiopathic Bone Marrow Failure and Cytopenia Consortium Steering Committee Meeting
The BMFDC Team

From the Left:

T.P. Loughran, Jr., M.D., Penn State Cancer Institute, Hershey, PA;
P.K. Epling-Burnette, Ph.D.,
H. Lee Moffitt Cancer Center, Tampa, FL;
H. Saba, M.D., H. Lee Moffitt Cancer Center,Tampa, FL;
G.M. Spinnela, M.D.,
Office of Rare Diseases, NIH, Bethesda, MD;
J.P. Maciejewski, M.D., Ph.D.,
Cleveland Clinic, Cleveland, OH;
M. Baker, M.S.,
AA&MDSIF, Annapolis, MD;
J. Malloy, M.S.,
H. Lee Moffitt Cancer Center, Tampa, FL;
D. Cuthbertson, M.S.,
H. Lee Moffitt Cancer Center, Tampa, FL;
E. Collier, M.D.,
National Center for Research Resources, NIH, Bethesda, MD;
R. Paquette, M.D., UCLA, Los Angeles, CA.